510(k) · Cleared
ClearedLifesign Met, Status Stik Met, Accusign Stik Met, Accustik Met, Accusign Met, Status DS Met
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Princeton BioMeditech Corp. · MVO Kit, Test, Multiple, Drugs Of Abuse, Over The Counter
Cleared on May 23, 2002 as substantially equivalent to K990786 (Princeton BioMeditech Corp., 1999) after a 153-day review. Its family tree reaches back 1 generation to 1999. 1 later device descends from it.
- Decided
- May 23, 2002
- Review
- 153 days
- Class
- Class U
- Product code
- MVO
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K990786 (1999). 1 later device descends from it, 1 citing it directly.
- Root · 1 generation backK990786 Accusign Doa 10, Accusign Doa 10 Panel, Acusign…Princeton BioMeditech Corp. · 1999
- This deviceK014192 Lifesign Met, Status Stik Met, Accusign Stik Met, Accustik Met…Princeton BioMeditech Corp. · 2002
- Descendant · cites it directly · 0 of its ownK023837 Lifesign Home Drug Test (Ecstasy/Met), Status Stik Met & Mdma…Princeton BioMeditech Corp. · 2003
Most influential descendants
Showing 1 of 1 · See all- K023837Lifesign Home Drug Test (Ecstasy/Met), Status Stik Met & Mdma, Accusign Stik Met & Mdma…Princeton BioMeditech Corp. · 2003 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K990786 | Accusign Doa 10, Accusign Doa 10 Panel, Acusign… | Princeton BioMeditech Corp. | 1999 | — |
| 0 (this device) | K014192 | Lifesign Met, Status Stik Met, Accusign Stik Met, Accustik Met, Accusign Met… | Princeton BioMeditech Corp. | 2002 | — |
| +1 | K023837 | Lifesign Home Drug Test (Ecstasy/Met), Status Stik Met & Mdma, Accusign Stik… | Princeton BioMeditech Corp. | 2003 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2003 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MVO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K990786 | Accusign Doa 10, Accusign Doa 10 Panel, Acusign Met/Opi/Coc/THC/PCP/Bzo/Bar/MTD/Tca/Amp…Summary page 1…tamine in urine Classification Name: Drugs of Abuse Analysis Systems, Toxicology (91LAG for HPLC) Identification of legally marketed device to which claims equivalence: k990786; Status DS™DOA 10 (MET/OPI/COC/THC/PCP/BZO/BAR/MTD/TCA/AMP) Device Description: Life Sign® Home Drug Test (MET) is simple one st… | 1999 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K023837 | Lifesign Home Drug Test (Ecstasy/Met), Status Stik Met & Mdma, Accusign Stik Met & Mdma… | 2003 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All MVO devicesMVO Kit, Test, Multiple, Drugs Of Abuse, Over The Counter: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · MVO
FDA has decided no MVO device since 2007.
Median 510(k) review, days · MVO
Too few MVO 510(k)s in any year since 2007 to give a median.
Recalls per year · MVO
1so far in 2026, the most since 2007
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · MVO
1in 2015
MAUDE reports naming product code MVO, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 1 |
| 2008 | 0 | — | 0 | 1 |
| 2009 | 0 | — | 0 | 2 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 3 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 1 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 1 | — |
What is it indicated for?
Immunoassay for the qualitative detection of methamphetamine at the cut-off of 1000 ng/mL in urine to assist in screening of drugs of abuse samples at home and work place.
For In vitro Diagnostic Use
Immunoassay for the qualitative detection of methamphetamine at the cut-off of 1000 ng/mL in urine to assist in screening of drugs of abuse samples. For In vitro Diagnostic Use
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K014192 · printed Nov 3, 2026
Cite this page
510(k) Report. “K014192: Lifesign Met, Status Stik Met, Accusign Stik Met, Accustik Met, Accusign Met, Status DS Met.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K014192
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026